BETTINA SIEBENECK: Open Payments
NPI 1093079030 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,516 in 144 payments from 39 companies in 2025. Trend: 2023 $3,848 · 2024 $2,825 · 2025 $3,516
Food & beverage: $3,516
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $482 |
| Merck Sharp & Dohme LLC | 13 | $360 |
| Novartis Pharmaceuticals Corporation | 13 | $301 |
| Daiichi Sankyo Inc. | 12 | $281 |
| Janssen Biotech, Inc. | 10 | $186 |
| Incyte Corporation | 8 | $158 |
| GENZYME CORPORATION | 4 | $120 |
| Genmab U.S., Inc. | 4 | $113 |
| JAZZ PHARMACEUTICALS INC. | 3 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $101 |
Products named: KEYTRUDA, Enhertu, AYVAKIT, Epkinly, IMFINZI, LYNPARZA, ZEPZELCA, RYTELO.
Industry payments across AZ — which companies pay providers there.
